Table 1. Lipid droplets in glioma patient tissues and overall survival.

Two separate areas from each patient in TMA were stained by TIP47 or Ki67 antibody and imaged by confocal or light microscopy. The number of LDs or Ki67 positive percentage was quantified by ImageJ software or Immunoratio, an online publically available application (49). Five images were taken from each tissue and averaged. Control dysplasia is a disorganized piece of brain tissue that was causing seizures, but it is neither cancerous nor precancerous. The term “dysplasia” represents something very different in neuropathology compared to elsewhere in the body.

ID#	age at surgery	Gender	initial diagnosis	LDs/cell	Ki67 positive%	OS (months)
6	51	F	dysplasia	0.00	0.2	64.5
13	35	M	dysplasia	0.00	0.3	35.2
24	41	M	dysplasia	0.00	0.1	102.1
33	7	F	dysplasia	0.00	0.6	50.1
42	36	M	dysplasia	0.00	0.0	32.3
60	50	M	dysplasia	0.00	0.5	20.2
70	34	M	dysplasia	0.00	0.2	109.7
103	22	M	dysplasia	0.00	0.1	31.4
107	26	M	dysplasia	0.00	0.4	33.6
86	18	F	PA	0.00	0.7	90.5
93	15	M	PA	0.00	1.2	70.2
15	26	F	A2	0.23	0.5	42.5
57	24	M	A2	0.04	2.3	144.8
69	32	M	A2	0.00	1.7	63.5
77	29	M	A2	0.00	0.3	74.7
85	38	M	A2	0.00	0.2	82.6
88	41	M	A2	0.00	2.2	85.7
95	45	F	A2	0.00	2.5	20.3
101	73	M	A2	0.07	0.6	57.5
105	26	F	A2	0.00	1.8	6.8
7	27	M	A2-3	0.10	1.4	60.2
23	25	M	A2-3	0.23	2.3	41.0
10	59	M	AA	0.30	1.7	21.1
12	50	F	AA	1.21	1.0	82.3
41	49	F	AA	0.66	1.9	39.1
46	39	F	AA	0.00	10.2	41.6
59	48	F	AA	0.00	4.6	100.5
79	29	M	AA	0.17	9.8	26.5
98	36	M	AA	1.93	19.6	30.0
100	42	F	AA	0.01	2.0	26.8
104	23	M	AA	0.00	6.4	14.5
5	80	F	GBM	4.10	18.5	15.7
9	54	M	GBM	5.72	0.9	3.3
11	63	M	GBM	14.41	5.7	19.3
21	62	M	GBM	1.63	9.3	4.8
22	72	M	GBM	16.20	11.5	8.3
25	67	M	GBM	0.00	3.0	4.2
26	54	M	GBM	23.37	16.9	23.7
28	46	M	GBM	49.08	4.4	0.3
30	59	M	GBM	11.33	9.8	14.5
34	53	M	GBM	1.75	4.5	0.9
35	64	F	GBM	36.19	22.1	15.6
38	50	F	GBM	12.18	26.7	2.0
39	62	F	GBM	3.25	6.7	29.3
43	51	F	GBM	2.89	15.1	21.1
44	67	F	GBM	0.39	4.8	0.5
45	56	M	GBM	4.52	2.5	35.6
48	74	F	GBM	5.82	6.6	15.1
49	62	M	GBM giant cell	5.83	13.3	72.9
52	50	F	GBM	3.21	3.9	43.7
54	42	M	GBM	0.91	8.7	13.3
56	64	M	GBM	16.93	6.8	6.0
58	51	M	GBM	12.54	10.5	8.0
65	67	M	GBM	0.16	7.1	10.9
66	77	M	GBM	0.56	2.4	18.1
67	31	M	GBM	2.25	13.2	71.5
68	79	M	GBM	8.74	6.3	2.2
71	59	F	GBM	8.31	14.8	8.2
76	62	F	GBM	3.16	4.6	20.3
80	59	M	GBM	24.42	10.7	9.3
81	76	F	GBM	17.91	20.0	8.4
82	78	F	GBM	5.84	9.2	0.9
83	76	M	GBM	0.02	4.9	30.8
84	56	M	GBM	1.48	6.5	7.5
87	69	M	GBM	28.55	12.4	2.3
89	56	M	GBM	1.22	3.3	17.8
90	72	F	GBM	7.09	6.2	30.4
94	26	F	GBM	13.94	4.2	5.1
96	64	F	GBM	12.51	11.1	9.3
102	44	F	GBM	18.04	2.2	4.0
106	70	M	GBM	19.69	22.4	8.9
108	72	F	GBM	0.50	2.6	26.7
109	42	M	GBM	55.41	27.6	2.6
8	26	M	O2	0.00	0.5	49.4
14	37	M	O2	0.03	1.2	53.1
16	31	M	O2	1.50	3.0	91.7
18	35	M	O2	0.15	0.6	97.3
20	38	M	O2	0.02	0.7	30.6
32	25	M	recurrent O2	5.22	1.8	82.9
36	38	M	O2	0.00	1.8	29.2
37	45	F	O2-3	0.00	2.6	66.6
50	27	F	O2	0.13	1.3	36.4
62	42	M	O2	0.00	1.9	64.4
63	31	F	O2	0.00	1.3	52.2
64	32	F	O2	0.00	1.6	60.8
72	58	M	O2	0.10	3.7	89.2
73	27	M	O2	0.08	1.4	98.2
91	40	F	O2	4.16	2.0	52.2
92	27	M	O2	0.00	1.8	83.3
99	65	M	O2	0.00	1.4	59.2
2	62	F	AO	3.91	4.8	60.8
4	56	F	AO	0.00	3.0	0.4
29	51	M	AO	12.24	18.6	4.5
31	32	M	AO	3.83	0.8	46.4
40	57	M	AO	6.39	6.7	15.1
47	32	F	AO	0.30	1.7	138.5
51	44	M	AO	0.40	2.5	15.3
53	49	M	AO	0.30	2.7	29.0
61	25	M	progressed to AO	1.45	11.8	82.9
78	37	F	recurrent AO	0.45	9.0	145.0